Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Tables)

v3.7.0.1
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2017
Accounting Policies [Abstract]  
Schedule of computation of potentially dilutive securities

For all periods presented in this report, convertible notes, stock options, and warrants were not included in the computation of diluted net loss per share because such inclusion would have had an antidilutive effect.

  

    Three months ended  
    March 31,  
    2017     2016  
Excluded potentially dilutive securities (1):                
                 
Convertible note - principal     702,247       -  
Consulting warrants to purchase common stock     12,500       491,364  
Options to purchase common stock     892,129       767,074  
Financing and IPO warrants to purchase common stock     2,384,464       975,380  
Total potential dilutive securities     3,991,340       2,233,818  

  

  (1) The number of shares is based on the maximum number of shares issuable on exercise or conversion of the related securities as of the period end. Such amounts have not been adjusted for the treasury stock method or weighted average outstanding calculations as required if the securities were dilutive.